¿ë¾î ] ¿¬±¸¹æ¹ý ] ÇöȲ ] ¹ß»ý¿øÀΠ] ºÐ¸¸ ] ôÃß¼ö¼ú ] º´¿ø°¨¿° ] Áø·á°ú¸ñº° ºÐ·ù ] ÀÇ·á ÇàÀ§º° ºÐ·ù ] Áúȯº° ºÐ·ù ] °ú½Ç À¯Çüº° ºÐ·ù ] ´ëÃ¥ ] ÀÇÇÐÀû ÀÇ»ç°áÁ¤·Ð ] ¹æ¾îÁø·á ] ÆÇ·Ê ] ¼Ò¼Û¿ÜÀû ÀÇ·áºÐÀïÀÇ ÇØ°á ] ÀÇ·áºÐÀïÁ¶Á¤¹ý ] ÀÇ»çÀÇ ¹ýÀû Àǹ« ] ȯÀÚÃøÀÇ ½ÃÀ§ ] ÀÇ·á¹ý·ü ] ¹ý·ü ] ±âÃÊÀÇÇР] ÀÌ»ó¼Ò°ß ] ÀÓ»óÀÇÇР] Áõ·Ê ] ´ºÁú·£µå ] ¹Ì±¹ ] µ¶ÀÏ ] ¿µ±¹ ] ¿À½ºÆ®·¹Àϸ®¾Æ ] ÀÌÅ»¸®¾Æ ] ÀϺ» ] Áß±¹ ] ÇÁ¶û½º ] ij³ª´Ù ] ±âŸ ±¹°¡ ] ¹®Çå ] ÀÇ·á¼Ò¼Û ] °Ë»ö ] Medical malpractice ] Kunstfehler in Deutschland ]


¡¡

[ÇöÀçÀ§Ä¡]: Ȩ> ÀÓ»óÀÇÇÐ> ºóÇ÷

ºóÇ÷(Anemia)

¾Ç¼º ºóÇ÷ ] °Å´ëÀû¾Æ±¸¼º ºóÇ÷ ] ¿ëÇ÷¼º ºóÇ÷ ]

¡¡

  • ºóÇ÷ÀÇ ÈçÇÑ ¿øÀÎ

    • ö°áÇÌÁõ ºóÇ÷
    • Thalassemia
    • ¸¸¼º¿°Áõ, °¨¿°, ¶Ç´Â ¾Ç¼ºÁ¾¾ç
    • °â»óÀûÇ÷±¸Áõ
    • ºñŸ¹Î B12 ¶Ç´Â ¿±»ê°áÇÌÁõ
    • ¿ø¹ß¼º °ñ¼öÁúȯ(°ñ¼öÀÌÇü¼ºÁõÈıº, ¹éÇ÷º´)
    • ¾ËÄÚ¿Ã µîÀÇ µ¶¼º¹°Áú
  • Áø´ÜÈ帧µµ

    • Figure 2 RBC = red blood cell; CRI = corrected reticulocyte index; ACD = anemia of chronic disease; AIHA = autoimmune hemolytic anemia
  • ¿øÀÎ

    • Á¤»óÀûÇ÷±¸ºóÇ÷(Normocytic anemia)

      • Increased red blood cell loss or destruction
        • Acute blood loss
        • Hypersplenism
        • Hemolytic disorders
          1. Congenital conditions
            • Hemoglobinopathies
              • Homozygous sickle cell disease (hemoglobin SS disease)
              • Heterozygous sickle hemoglobin C disease (hemoglobin SC disease)
          2. Disorders of red blood cell membranes
            • Hereditary spherocytosis
            • Hereditary elliptocytosis
          3. Red blood cell enzyme deficiencies
            • Glucose-6-phosphate dehydrogenase deficiency
            • Pyruvate kinase deficiency
          4. Acquired conditions
            • Mechanical hemolysis
              • Macrovascular disorders
              • Microangiopathic disorders
                • Disseminated intravascular coagulopathy
                • Hemolytic-uremic syndrome
                • Thrombotic thrombocytopenic purpura
              • Autoimmune hemolytic anemias
                • Warm-reactive anemias
                • Cold-reactive anemias
                • Drug-induced anemias
              • Paroxysmal nocturnal hemoglobinuria
      • Decreased red blood cell production
        1. Primary causes
          • Marrow hypoplasia or aplasia
          • Myelopathies
          • Myeloproliferative diseases
          • Pure red blood cell aplasia
        2. Secondary causes
          • Chronic renal failure
          • Liver disease
          • Endocrine deficiency states
          • Anemia of chronic disease
          • Sideroblastic anemias
      • Overexpansion of plasma volume
        • Pregnancy
        • Overhydration
  • ºóÇ÷ÀÇ Áø´Ü

    • Áø´Ü°Ë»ç

      1. Ç÷¾×¼¼Æ÷(ÀϹÝÇ÷¾×°Ë»ç, Complete blood count)

        • ÀûÇ÷±¸¼ö(Red blood cell count)

          • Hemoglobin

          • Hematocrit

        • ÀûÇ÷±¸Áö¼ö(Red blood cell indices)

          • Mean cell volume (MCV)

          • Mean cell hemoglobin (MCH)

          • Mean cell hemoglobin concentration (MCHC)

          • Red cell distribution width (RDW)

            • RDW-CV: 13.1 %

            • RDW-SD: 42.5 fL

        • ¹éÇ÷±¸¼ö(White blood cell count)

          • Cell differential

          • Nuclear segmentation of neutrophils

        • Ç÷¼ÒÆÇ¼ö(Platelet count)

        • ¼¼Æ÷ÇüÅÂ(Cell morphology)
          • ¼¼Æ÷Å©±â(Cell size)

          • Hemoglobin content

          • Polychromasia

          • Ç¥Àû¼¼Æ÷
            • ö°áÇ̼º ºóÇ÷
            • Thalassemia
            • °â»óÀûÇ÷±¸Áõ
            • Çì¸ð±Û·Îºó Cº´
            • °£ Áúȯ
            • ºñÀåÀýÀç¼ú ¶Ç´Â ÀúºñÀåÁõ(Hyposplenism)
          • Anisocytosis (ÀûÇ÷±¸ Å©±âÂ÷ÀÌ)
            • ö°áÇ̼º ºóÇ÷
            • Sideroblastic anemia
          • Poikilocytosis(ÀûÇ÷±¸ ÇüÅÂÂ÷ÀÌ)
            • ö°ãÇÌÁõ
            • Thalassemia(´«¹°¹æ¿ï ÇüÅÂ)
            • °ñ¼ö¼¶À¯È­Áõ(´«¹°¹æ¿ï ÇüÅÂ)
          • ´ÙºÐÀý¼º Áß¼º±¸/°Å´ëÀû¾Æ±¸
            • ºñŸ¹Î B12 °áÇÌÁõ
            • ¿±»ê °áÇÌÁõ
          • Basophillic stippling
            • ³³Áßµ¶Áõ
            • Thalassemia
            • ½ÉÇÑ ¿ëÇ÷
          • °â»óÀûÇ÷±¸
            • °â»óÀûÇ÷±¸ ºóÇ÷
          • ±¸»óÀûÇ÷±¸
            • À¯Àü¼º ±¸»óÀûÇ÷±¸Áõ
            • ÀÚ°¡¸é¿ª¼º ¿ëÇ÷¼º ºóÇ÷
            • ÇѳÃÀÀÁý¼Ò
          • ÀûÇ÷±¸ ÆÄÆí
            • Ç÷°ü³» ¿ëÇ÷
              • ¹ßÀÛ¼º ¾ß°£Ç÷»ö¼Ò´¢Áõ
              • Àΰø½ÉÀåÆÇ¸· ¶Ç´Â ±âŸ ºÐÀý¼º ¿ëÇ÷
              • Ç÷Àü¼º Ç÷¼ÒÆÇ°¨¼Ò¼º ÀÚ¹ÝÁõ
          • Heinz body
            • G6PD º´
            • Thalassemia
            • ±âŸ Ç÷»ö¼ÒÁõ
            • ºñÀåÀýÁ¦¼ú

      2. ¸Á»óÀûÇ÷±¸¼ö(Reticulocyte count)

        • °ñ¼ö¿¡¼­ »ý»êµÇ¾î Ç÷¾×À¸·Î ¹èÃâµÈ Á÷ÈÄÀÇ ÀûÇ÷±¸

        • ºóÇ÷ÀÇ °¨º°Áø´ÜÀÇ Áß¿äÇÑ °Ë»ç

        • They are identified by staining with a supravital dye that precipitates the residual ribosomal RNA. These precipitates appear as blue or black punctate spots. This residual RNA is metabolized over the first 24 to 36 h of the reticulocyte's lifespan in circulation.

        • Á¤»ó¼öÄ¡

          • 1 - 2%

          • ÇÏ·ç Àüü ÀûÇ÷±¸ÀÇ 0.8-1.0%¸¦ º¸Ãæ

        • In the initial classification of anemia, the patient's reticulocyte count is compared with the expected reticulocyte response.

        • °ñ¼öÀÇ ±â´ÉÀÌ Á¤»óÀÎ °æ¿ì Áߵ(<10 g/dL)ÀÇ ºóÇ÷ÀÌ ÀÖ´Â °æ¿ì ºóÇ÷¹ß»ý 10ÀÏ À̳»¿¡ ¸Á»óÀûÇ÷±¸ »ý»êÀº 2-3¹è·Î »ó½ÂÇÑ´Ù.

        • ºóÇ÷ÀÌ Áö¼ÓµÊ¿¡µµ ¸Á»óÀûÇ÷±¸¼öÄ¡°¡ Á¤»óÀÇ 2-3¹è ÀÌÇÏ¿¡ ¸Ó¹«¸¥´Ù¸é °ñ¼öÀÇ ±â´ÉÀÌ»óÀ» ÀǹÌÇÑ´Ù.

        • ¸Á»óÀûÇ÷±¸¼öÄ¡ÀÇ ÇØ¼®

          • 2´Ü°èÀÇ ±³Á¤ÀÌ ¸Á»óÀûÇ÷±¸¼öÄ¡ÀÇ ±³Á¤ÀÌ ÇÊ¿äÇÏ´Ù.

          • 1´Ü°è: Àý´ë¸Á»óÀûÇ÷±¸¼ö(absolute reticulocyte count)ÀÇ °è»ê

            • reticulocyte count : 9%, hemoglobin: 7.5 g/dL, hematocrit : 23%ÀÎ °æ¿ì
            • absolute reticulocyte count = 9¥ª(7.5/15) = 4.5%, ȤÀº
            • absolute reticulocyte count = 9¥ª(23/45) = 4.5%
          • 2´Ü°è: ¸Á»óÀûÇ÷±¸»ý»êÁö¼ö(reticulocyte production index)ÀÇ °è»ê
            • ¹Ì¼º¼÷¸Á»óÀûÇ÷±¸ ¼öÄ¡ÀÇ ±³Á¤
            • reticulocyte count is 9%, hemoglobin 7.5 gm/dL, hematocrit 23%,
            • reticulocyte production index

              (7.5/15)(hemoglobin correction)
              = 9¥ª ______________________________ = 2.25
              2 (maturation time correction)

      3. Iron supply studies

        • Serum iron

        • Total iron-binding capacity

        • Serum ferritin, marrow iron stain

      4. °ñ¼ö°Ë»ç(Marrow examination)

        • ÈíÀΰ˻ç(Aspirate)

          • E/G ratio(ratio of erythroid to granulocytic precursors)

          • Cell morphology

          • Iron stain

        • Á¶Á÷°Ë»ç(Biopsy)

          • Cellularity

          • Morphology

        • °ñ¼ö°Ë»çÀÇ ÀûÀÀÁõ
          • ºóÇ÷ÀÌ ÀÇ½ÉµÉ °æ¿ì º¸Á¶ÀûÀÎ °Ë»ç
          • »ó±â°Ë»ç·Î Áø´ÜµÇÁö ¾Ê´Â ºóÇ÷
          • Ä¡·á¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â ºóÇ÷
          • °ñ¼ö¼¶À¯È­Áõ ¹× °ñ¼öÀÌÇü¼ºÁõÈıº, Àç»ýºÒ·®¼º ºóÇ÷, sideroblastic anemia °¡ ÀÇ½ÉµÉ ¶§
          • °ñ¼öħÀ±¼ºÁúȯÀÌ ÀÇ½ÉµÉ ¶§ : ¾Ç¼ºÁ¾¾ç, À°¾ÆÁ¾, °¨¿°Áúȯ
          • MCV°¡ °¨¼ÒµÇÁö ¾Ê°Å³ª Fe °Ë»ç°¡ È®½ÇÇÏÁö ¾Ê´Â µî ÃʱâÀÇ Ã¶°áÇ̼º ºóÇ÷À» È®ÀÎÇØ¾ßÇÒ °æ¿ì
      • ºóÇ÷À» ¹ß°ßÇÏ°í ¿øÀÎÀ» ã±â À§ÇÑ ÀÏÂ÷°Ë»ç
        • Complete blood count (CBC), index (RDWÆ÷ÇÔ)
        • ¸»ÃÊÇ÷¾×µµ¸»°Ë»ç
        • ¸Á»óÀûÇ÷±¸¼ö
      • »ó±â °Ë»ç¿¡¼­ ÀÌ»óÀÌ Àִ ȯÀÚ¸¦ À§ÇÑ °Ë»ç
        • ¸Á»óÀûÇ÷±¸¼ö »ó½Â --> ¿ëÇ÷¼ººóÇ÷À» ÀǽÉ
          • ¸»ÃÊÇ÷¾×µµ¸»°Ë»çÀÇ Àç°Ë
          • ¿ëÇ÷¿¡ ´ëÇÑ °Ë»ç
            • LDH (»ó½Â)
            • ÃÑ ºô¸®·çºó ¹× Á÷Á¢ ºô¸®·çºó(»ó½Â)
            • Haptoglobin(°¨¼Ò)
            • ´¢ hemosiderin(Ç÷°ü³»¿ëÇ÷¿¡¼­ »ó½Â)
              • i. ¹ßÀÛ¼º¾ß°£Ç÷»ö¼Ò´¢Áõ
              • ii. Àΰø½ÉÀåÆÇ¸·
          • ¿ëÇ÷ÀÇ Á¾·ù¸¦ ¾Ë±â À§ÇÑ °Ë»ç
            • °â»óÀûÇ÷±¸¸¦ º¸±â À§ÇÑ ¸»ÃÊÇ÷¾×µµ¸»°Ë»ç
            • ÀÌ»óÇ÷»ö¼ÒÁõÀ» ã±âÀ§ÇÑ Ç÷»ö¼Ò Àü±â¿µµ¿¹ý (Hemoglobin electrophoresis)
            • ÀÚ°¡¸é¿ª¼º ºóÇ÷À» ¾Ë±âÀ§ÇÑ Coombs °Ë»ç
            • G6PD°áÇÌÁõµîÀÇ È¿¼Ò°áÇÌÀ» ã±â À§ÇÑ ÀûÇ÷±¸ È¿¼Ò °Ë»ç¹ý
            • ÀûÇ÷±¸¸·°Ë»ç¹ý
              • i. Osmotic fragility test : À¯Àü¼º ±¸»óÀûÇ÷±¸Áõ
              • ii. Sucrose Iysis test : ¹ßÀÛ¼º¾ß°£Ç÷»ö¼Ò´¢Áõ
        • MCV °¨¼Ò, RDW Áõ°¡ --> ö°áÇ̼º ºóÇ÷À» ÀǽÉ
          • Ãß°¡·Î ÇÊ¿äÇÑ °Ë»ç
            • Fe(°¨¼Ò)
            • Total iron-binding capacity (TIBC)(»ó½Â)
            • Iron saturation (ºñ< 15%), ºñ =Fe/TIBC
          • ÇÊ¿äÇÑ °æ¿ì¿¡ ½ÃÇàÇÒ ¼ö ÀÖ´Â °Ë»ç
            • Ferritin(°¨¼Ò)
              • i. ±Þ¼º¹ÝÀÀÀÎÀÚÀÇ ÇϳªÀÌ¸ç °£ ÁúȯÀÌ ÀÖÀ» °æ¿ì¿¡ »ó½ÂÇÒ ¼ö ÀÖÀ½
              • ii. ºñ¿ëÀÌ ¸¹ÀÌ µé¸ç Áø´Ü¿¡ ÇʼöÀûÀÌÁö´Â ¾ÊÀ½
              • iii. ö°áÇÌÀÇ Ãʱ⿡´Â MCV°¡ Á¤»óÀ̸ç RDW¸¸ »ó½Â
        • MCV °¨¼Ò, RDWÁ¤»ó--> ´ÙÀ½ÀÇ µÎ °¡Áö °æ¿ì
          • Thalassemia
            • Ãß°¡·Î ÇÊ¿äÇÑ °Ë»ç
              • i. ö°áÇÌÀ» °¨º°Çϱâ À§ÇÑ Fe°Ë»ç
              • ii. Ç÷»ö¼ÒÀü±â¿µµ¿¹ý(alpha-thalassemia¿¡¼­´Â Á¤»ó)
              • iii. HBa2ÀÇ Á¤·®(beta-thalassemia minor¿¡¼­´Â »ó½Â)
              • iv. HbHº´À» ¾Ë±â À§ÇÑ Heinz body°Ë»ç
          • ¸¸¼ºÁúȯ¿¡ ÀÇÇÑ ºóÇ÷
            • ´Ù¸¥ÁúȯÀ» ¹èÁ¦ÇÔÀ¸·Î½á Áø´ÜÇÔ
            • ¿°Áõ¼ºÁúȯ(°áÁ¦Á¶Á÷Áúȯµî), ¾Ç¼ºÁ¾¾ç, HIV, ½ÅºÎÀüÁõ
        • MCV Á¤»ó, RDW Á¤»ó--> ´ÙÀ½ÀÇ ³×°¡Áö °æ¿ì
          • ±Þ¼º½ÇÇ÷
            • ÀϹÝÀûÀ¸·Î ¸Á»óÀûÇ÷±¸¼öÀÇ »ó½ÂÀÌ µ¿¹Ý
            • ¿øÀÎÀ» ¼­µÑ·¯ ã¾Æ¾ß ÇÔ
          • À¯Àü¼º ±¸»óÀûÇ÷±¸Áõ
            • Ãß°¡·Î ÇÊ¿äÇÑ °Ë»ç
              • i. ¸»ÃÊÇ÷¾×µµ¸»°Ë»ç
              • ii. Coombs °Ë»ç
              • iii. Osmotic fragility
          • ¸¸¼ºÁúȯ¿¡ ÀÇÇÑ ºóÇ÷ÀÇ °æ¿ì ´ë°³ MCV¿Í RDW´Â Á¤»ó
          • ³»ºÐºñÁúȯ (¿¹, °©»ó¼±Áúȯ)
          • Sideroblastic anemia
        • MCV Á¤»ó, RDW »ó½Â
          • ö°áÇ̼º ºóÇ÷ÀÇ Ãʱâ
          • ÀÌ»óÇ÷»ö¼ÒÁõ
            • Ãß°¡·Î ÇÊ¿äÇÑ °Ë»ç
              • i. Ç÷»ö¼ÒÀü±â¿µµ¿
              • ii. ÀûÇ÷±¸¸·°Ë»ç
          • °ñ¼ö¼¶À¯È­Áõ
            • °ñ¼öÈíÀÎ ¹× Á¶Á÷°Ë»ç°¡ ÇÊ¿ä
          • °£ Áúȯ
          • ½ÅºÎÀü(´¢µ¶Áõ)
        • MCV »ó½Â, RDW»ó½Â
          • ºñŸ¹Î B12 ¶Ç´Â ¿±»ê°áÇÌÁõ
            • Ãß°¡ÀûÀ¸·Î ÇÊ¿äÇÑ °Ë»ç
              • i. ´ÙºÐÀý¼º Áß¼º±¸¸¦ º¸±âÀ§ÇÑ ¸»ÃÊÇ÷¾×µµ¸» °Ë»ç
              • ii. ÀûÇ÷±¸³ª Ç÷û³»ÀÇ ¿±»ê³óµµ
              • iii. Ç÷ûÀÇ ºñŸ¹Î B12
          • ÀÚ°¡¸é¿ª¼º ¿ëÇ÷¼ººóÇ÷
            • Ãß°¡·Î ÇÊ¿äÇÑ °Ë»ç
              • i. ¸Á»óÀûÇ÷±¸¼ö
              • ii. LDH, ºô¸®·çºó, haptoglobin
              • iii. Coombs °Ë»ç
              • iv. ±¸»óÀûÇ÷±¸¸¦ º¸±â À§ÇÑ ¸»ÃÊÇ÷¾×µµ¸»°Ë»ç
          • ¾ËÄڿõîÀÇ µ¶¼º¹°Áú
          • ÇѳÃÀÀÁý¼Òº´
          • °£ Áúȯ
          • ½ÅºÎÀü(´¢µ¶Áõ)
        • MCV »ó½Â,  RDW Á¤»ó
          • ¾ËÄÚ¿Ã ³²¿ë
            • Ãß°¡·Î ÇÊ¿äÇÑ °Ë»ç
              • i. ¿±»ê°ú ºñŸ¹Î B12ÀÇ ³óµµ
              • ii. ¾ËÄÚ¿Ã ÀÇÁ¸¼ºÀ¯¹«ÀÇ °Ë»ç
          • °©»ó¼± Áúȯ
            • Ãß°¡·Î ÇÊ¿äÇÑ °Ë»ç
              • i. ¿±»ê°ú ºñŸ¹Î B12ÀÇ ³óµµ
              • ii. FT4¿Í TSH
  • Ä¡·á

    • ¼öÇ÷

      • ´ÙÀ½ÀÇ °æ¿ì¿¡´Â Áï½Ã ¼öÇ÷ÀÌ ÇÊ¿äÇÏ´Ù.

        • the patient's condition has deteriorated within the last couple of days,

        • if clinical findings suggest a threat to life or a major organ system, or

        • if the patient has severe symptoms, an underlying condition such as heart disease that increases risk if hypoxia occurs, or active bleeding.

          • angina,

          • dyspnea at rest,

          • pleural effusion, and

          • dizziness or other signs of inadequate blood delivery to the brain.

          • Orthostatic hypotension often contributes to the last category.

  • ö°áÇ̼º ºóÇ÷(Iron Deficiency Anemia)

  • öÀû¾Æ±¸¼º ºóÇ÷(Sideroblastic Anemia)

  • ½ÇÇ÷¿¡ ÀÇÇÑ ºóÇ÷(Anemia of Blood Loss)

  • ¸¸¼º Áúȯ¿¡ ÀÇÇÑ ºóÇ÷(Anemia of Chronic Disorders) 

    • ¸¸¼º ¿°Áõ¿¡ ÀÇÇÑ ºóÇ÷ÀÇ ¹ß»ý±âÀü

  • Àç»ýºÒ·®¼ººóÇ÷(Aplastic Anemia)

  • Æ÷¸£ÇǸ°Áõ(Porphyrias)

  • ¸»¶ó¸®¾Æ(Malaria)

  • ¿ëÇ÷¼º ºóÇ÷

  • °Å´ëÀûÇ÷¸ð±¸ºóÇ÷(°Å´ëÀû¾Æ±¸¼ººóÇ÷, megaloblastic anemia)

  • ³ëÀÎÀÇ ºóÇ÷(Anemia in the Elderly)

    • °¨º°Áø´Ü

  • ÀÇ·á»ç°í

    • ÆÇ·Ê

      • ¡¡

    • Áõ·Ê

      • ¡¡

    • °í·Á»çÇ×

      • ºÎÀûÇÕÇ÷¾×ÀÇ ¼öÇ÷

      • ¼öÇ÷°¨¿°ÀÇ ¹ß»ý

      • ¿ëÇ÷¼ººÎÀÛ¿ëÀÇ ¹ß»ý¿¡ ´ëÇÑ ´ëóÀÇ ¹ÌÈí

      • ºóÇ÷ÀÇ Ä¡¸íÀû ¿øÀÎ(¿¹, Á¾¾ç)¿¡ ´ëÇÑ Áø´ÜÁö¿¬

      • ºÎÀûÀýÇÑ Ä¡·á ¹× ºÎÀûÀýÇÑ È¯ÀÚ°ü¸®

      • ¼öÇ÷ÀÇ Áö¿¬

        • ÃâÇ÷¼º ºóÇ÷

        • ÀÚ°¡¸é¿ª¼º ¿ëÇ÷¼º ºóÇ÷

  •  Âü°í¹®Çå ¹× À¥»çÀÌÆ®

    1. ³»°ú¿Ü·¡Áø·áÆí¶÷. ±ºÀÚÃâÆÇ»ç

    2. A focused approach to anemia

    3. http://www.anemia.org

    4. http://www.hypertension-consult.com/Secure/textbookarticles/Primary_Care_Book/185.htm

  • ±âŸ °ü·Ã»çÀÌÆ® ¹× ¹®Çå

    1. ¡¡

e ÀÇ·á»ç°í¿¬±¸¼Ò ¸ÞÀÏ
º» »çÀÌÆ®ÀÇ Á¤º¸´Â ¹Ì¿Ï¼ºÀ̸ç Âü°í¿ë¿¡ ºÒ°úÇÕ´Ï´Ù.